Comparative efficacy of fenofibrate/pravastatin/ezetimibe and simvastatin/ezetimibe therapies in type 2 diabetic patients with combined hyperlipidaemia and cardiovascular disease

被引：0
|
作者：
Farnier, M. [1 ]
Steinmetz, A. [2 ]
Csaszar, A. [3 ]
Retterstol, K. [4 ]
Dluzniewski, M. [5 ]
机构：
[1] Point Med, Dijon, France
[2] St Nikolaus Stiftshosp GmbH, Andernach, Germany
[3] State Hlth Ctr, Budapest, Hungary
[4] Oslo Univ Hosp Rikshosp, Oslo, Norway
[5] Warsaw Hosp, Warsaw, Poland
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1296
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment
    Derosa, G.
    D'Angelo, A.
    Franzetti, I. G.
    Ragonesi, P. D.
    Gadaleta, G.
    Scalise, F.
    Ciccarelli, L.
    Piccinni, M. N.
    Cicero, A. F. G.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (03) : 267 - 276
  • [22] Comparative efficacy of ezetimibe plus simvastatin combined therapy vs. simvastatin monotherapy for individuals with reduced estimated glomerular filtration rate
    Stanifer, J. W.
    Charytan, D. M.
    White, J.
    Lokhnygina, Y.
    Cannon, C.
    Blazing, M. A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1205 - 1205
  • [23] EFFICACY AND SAFETY OF LONG-TERM COADMINISTRATION OF FENOFIBRATE AND EZETIMIBE IN PATIENTS WITH COMBINED HYPERLIPIDEMIA: RESULTS OF THE EFECTL TRIAL
    Oikawa, S.
    Yamashita, S.
    Nakaya, N.
    Sasaki, J.
    Kono, S.
    ATHEROSCLEROSIS, 2016, 252 : E230 - E230
  • [24] Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study
    Oikawa, Shinichi
    Yamashita, Shizuya
    Nakaya, Noriaki
    Sasaki, Jun
    Kono, Suminori
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (01) : 77 - 94
  • [25] Efficacy and safety of Ezetimibe/Simvastatin coadministered with extended release niacin in patients with type IIa or IIb Hyperlipidemia
    Fazio, Sergio
    Brown, B. Greg
    Guyton, John R.
    Polis, Adam
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A325 - A325
  • [26] EFFICACY AND SAFETY OF EZETIMIBE/SIMVASTATIN COADMINISTERED WITH EXTENDED RELEASE NIACIN IN PATIENTS WITH TYPE IIA OR IIB HYPERLIPIDEMIA
    Fazio, S.
    Brown, B. G.
    Guyton, J. R.
    Polis, A.
    Tomassini, J. E.
    Tershakovec, A. M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 16 - 16
  • [27] Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia
    Durrington, PN
    Tuomilehto, J
    Hamann, A
    Kallend, D
    Smith, K
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 64 (02) : 137 - 151
  • [28] Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients
    Derosa, Giuseppe
    Maffioli, Pamela
    Salvadeo, Sibilla A. T.
    Ferrari, Ilaria
    Gravina, Alessia
    Mereu, Roberto
    Palumbo, Ilaria
    D'Angelo, Angela
    Cicero, Arrigo F. G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) : 1973 - 1983
  • [29] Evaluation of ezetimibe/simvastatin versus rosuvastatin in hypercholesterolaemic patients with type 2 diabetes or metabolic syndrome
    Catapano, A. L.
    Ballantyne, C. M.
    Davidson, M. H.
    Brady, W. E.
    Gazzara, R. A.
    Tomassini, J. E.
    Tershakovec, A. M.
    DIABETOLOGIA, 2006, 49 : 73 - 74
  • [30] Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia
    Tomassini, J. E.
    Mazzone, T.
    Goldberg, R. B.
    Guyton, J. R.
    Weinstock, R. S.
    Polis, A.
    Jensen, E.
    Tershakovec, A. M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (09): : 855 - 864
12345